The kind of COVID-19 herd immunity we can realistically expect
How does the COVID-19 pandemic end? A lot of public health rhetoric suggests the goal is what has sometimes been dubbed "COVID zero." When we talk about "stopping the spread," for instance, we envision a scenario where the virus dies out among the general population because each infected person is unable to transmit the disease either by encountering no one or encountering only immune people.
It is possible to end communicable illness this way. That's what we did with smallpox worldwide and polio in the Americas with vaccine-induced herd immunity. Other illnesses, like measles, which we commonly vaccinate against, aren't quite eradicated, but outbreaks are rare and serious illness among the vaccinated even rarer.
But it increasingly doesn't seem like that's the path COVID-19 will take, even if we get at or near total vaccine adoption. What looks more likely now — and what public health experts are increasingly acknowledging — is that COVID-19 will become an endemic illness, something that is always with us and which immunity dramatically mitigates but never eliminates. The idea, as Harvard immunologist Yonatan Grad has explained, is that "enough people [would] gain immune protection from vaccination and from natural infection such that there [would] be less transmission and much less COVID-19-related hospitalization and death, even as the virus continues to circulate."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
If that's where we're headed, we shouldn't expect to categorically stop the spread like we did with smallpox-style or measles-style herd immunity. We should anticipate herd immunity more like what we have for the common cold: Our bodies are almost always competent to fight the illness, and the typical risk it poses is annoyance or a few days in bed.
Indeed, for our children and later generations who grow up among endemic COVID-19, it's possible the novel coronavirus will join the other four coronaviruses as a common cold pathogen. It may become something everyone catches somewhat regularly, beginning in childhood, when risk is low, and building immunity for older years, when risk would otherwise be higher. (Here's a paper at Science which explains how that could work.)
In that case, the people who say COVID-19 is "just a cold" now are wrong, because getting exposed for the first time when you're older is dangerous. But 50 years from now, when everyone is exposed as children, it may indeed be just a cold, perhaps indistinguishable from any other cold.
If that's the kind of herd immunity we should expect, discussions like this one with National Institute of Allergy and Infectious Diseases chief Anthony Fauci are significantly misleading and off-target. In that clip, Fauci talks about measles-style herd immunity, but what if common cold-style herd immunity is what's actually in the cards? Aiming for an impossibility won't make good policy.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Bonnie Kristian was a deputy editor and acting editor-in-chief of TheWeek.com. She is a columnist at Christianity Today and author of Untrustworthy: The Knowledge Crisis Breaking Our Brains, Polluting Our Politics, and Corrupting Christian Community (forthcoming 2022) and A Flexible Faith: Rethinking What It Means to Follow Jesus Today (2018). Her writing has also appeared at Time Magazine, CNN, USA Today, Newsweek, the Los Angeles Times, and The American Conservative, among other outlets.
-
How much of a blow is ICC arrest warrant for Netanyahu?
Today's Big Question Action by Hague court damages Israel's narrative that Gaza conflict is a war between 'good and evil'
By Chas Newkey-Burden, The Week UK Published
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
By Harriet Marsden, The Week UK Published
-
'The Hum': the real-life noise behind The Listeners
In The Spotlight Can some of us also hear the disturbing sound that plagues characters in the hit TV show – and where is it coming from?
By Chas Newkey-Burden, The Week UK Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published